Abstract:Diabetes mellitus (DM) is characterized of prolonged hyperglycemia, impaired vascularization, and serious complications, such as blindness and chronic diabetic wounds. About 25% of DM patients are estimated to encounter impaired healing of diabetic wounds, often leading to lower limb amputation. Multi-factors are attributed to the non-healing property of diabetic wounds, including hyperglycaemia, chronic inflammation, and impaired angiogenesis. It is imperative to develop more efficient treatment strategies to tackle with healing difficulties in diabetic wounds. Mesenchymal stem cell (MSC)-derived extracellular vesicles (EVs) are promising for diabetic wound healing considering their anti-inflammatory, pro-angiogenic and pro-proliferative activities. A histone deacetylase 7 (HDAC7)-derived 7-amino acid peptide (7A) was shown to be highly effective for angiogenesis. However, it has never been investigated if MSC-EVs are synergistic with 7A for the healing of diabetic wounds. Herein we propose that MSC-EVs can be combined with 7A to greatly promote diabetic wound healing. The combination of EVs and 7A significantly improved both migration and proliferation of skin fibroblasts. Moreover, EVs alone significantly suppressed LPS-induced inflammation in macrophages, and notably, the combination treatment showed even better suppression effect. Importantly, the in vivo study revealed that the combination therapy of EVs and 7A in alginate hydrogel was more efficient for healing of diabetic wounds in rats than monotherapy of either EVs or 7A hydrogel. The underlying mechanisms include suppression of inflammation, improvement of skin cell proliferation and migration, and enhanced collagen fiber disposition and angiogenesis in wounds. Collectively, the MSC-EV-7A hydrogel potentially constitutes a novel therapy for efficient healing of chronic diabetic wounds.

Efficient healing of diabetic wound by MSC-EV-7A composite hydrogel via suppression of inflammation and enhancement of angiogenesis